Long-term care (LTC) pharmacists are geriatric medication experts. In the past, LTC pharmacists have been most recognized for their efforts in helping to keep long-term care (LTC) facilities in compliance with regulatory requirements. However, as the healthcare landscape moves toward outcome-based reimbursement and value-based purchasing, LTC communities are wise to focus on the LTC pharmacists’ value in improving medication-related outcomes.
The primary referral sources for LTC facilities are hospitals, which have increased expectations around quality with a focus on reducing length of stay, discharging patients to less costly settings, fewer rehospitalizations and greater interest in five-star ratings. LTC and post-acute providers who demonstrate efficient, high-quality care will become the providers of choice within preferred provider networks. Additionally, the Centers for Medicare & Medicaid Services (CMS) continues to create direct incentives to improve and is establishing a mandatory skilled nursing facility (SNF) Value-Based Purchasing program which will affect payments beginning in 2019 and has finalized inclusion of a 30-day, all-cause readmission measure.
Providing effective patient-centered care requires considerable teamwork. Consider the statement regarding teams made by the American College of Physicians in 2013: “Although physicians have extensive education, skills, and training that make them uniquely qualified to exercise advanced clinical responsibilities within teams, well-functioning teams will assign responsibilities to advanced practice registered nurses, other registered nurses, physician assistants, clinical pharmacists, and other health care professionals for specific dimensions of care commensurate with their training and skills to most effectively serve the needs of the patient.”
The statement emphasizes the need for well-designed functional “teams” in order to better manage resident care, while also acknowledging the need for a pharmacist to be an integral participatory member of the healthcare team.
Optimizing medication management is complex and is most effective when there are cooperative relationships among physicians, nurses, nurse aides, pharmacists, other healthcare professionals, residents and families. A team approach promotes optimal use of medications, reduces adverse drug events (ADEs) and promotes cost-effective drug-prescribing practices. This collaboration provides better insight around the resident’s needs, typical behaviors, and responses; while also increasing the number of persons who can observe the resident before and after a medication is started.
LTC facilities manage the care for medically complex patients who routinely receive 8 to 10 medications per day to manage multiple chronic conditions. LTC pharmacists focus on optimizing medication management and improving quality outcomes and have become more involved with prescribers, nurses, other healthcare team members, family members and residents.
Adverse drug events
At least monthly, the LTC pharmacists review each resident’s medical record and conduct a comprehensive medication regimen review. Based on this review and interactions with the healthcare team, LTC pharmacists make recommendations to improve medication management. These may include recommendations to adjust medication dosages, discontinue inappropriate or unnecessary medications, monitor and make recommendations on medication therapy based on patient vital signs or labs based on patient specific goals, consider cost effective alternative therapies and/or consider treatment options per evidence-based clinical practice guidelines. The value of medication regimen reviews by LTC pharmacists has been recognized as improving prescribing and potentially decreasing costs.
Inappropriate medication use can lead to substantial healthcare costs, including increased ADEs, emergency room visits and hospitalizations. One of the most important roles of LTC pharmacists is to evaluate the entire medication delivery process to help identify and prevent ADEs. With the pending CMS focus on 30-day rehospitalizations rates, ADEs should be viewed as one of the most likely contributors of potential negative outcomes. Studies suggest that at least one in seven LTC residents will be hospitalized as a result of an ADE.
CMS recently initiated “Medication Adverse Drug Event” focus surveys noting that one in three SNF residents is harmed by an adverse event or temporary harm event within the first 35 days of a SNF stay, and 37 percent of those adverse events are related to medication. The second-most frequent cause of ADEs is excessive bleeding related to anticoagulant use—causing harm ranging from hospitalization to death. As many as 50 percent of ADEs are believed to be preventable, and LTC pharmacists can provide essential education to LTC team members on how to recognize the potential side effects and triggers of ADEs.
When quality-of-care issues—including medication management—are addressed utilizing a team approach, patients are more likely experience positive quality outcomes. The facility can achieve additional benefits related to their financial viability and business outlook. Facility-wide improvement initiatives with predetermined outcome goals and measures are essential in order to achieve optimal medication management practices.